General Information
Revision date
2019-03-15
Product name
Modified Listeria Moxalactam Supplement
REACH No
This
Manufacturer Name
HiMedia Laboratories Private Limited
Emergency telephone
Please contact the regional HiMedia representation in your country
Icons in SDS
Company Information
company name
HiMedia Laboratories Private Limited
e-mail address of the competent person responsible for the Safety Data Sheet
info@himedialabs.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H317, H334
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
2.1 Classification of the substance or mixture
CLP Classification-Regulation (EC) No. 1272/2008[EU-GHS/CLP] Sensitisation, Skin, (Category 1), H317 Sensitisation, respiratory, (Category 1), H334 Acute toxicity, Oral, (Category 4), H302
2.2 Label elements
Labeling according to Regulation (EC) No.1272/2008
Signal word
Danger
Hazard statements
H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled H317 May cause an allergic skin reaction H302 Harmful if swallowed
Precautionary statements
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P270 Do not eat, drink or smoke when using this product. P301 + 310 IF SWALLOWED: Immediately call a POISON CENTER/doctor. P302 + P352 IF ON SKIN: wash with plenty of soap and water.
2.3 Other hazards
None .
